Matches in Wikidata for { <http://www.wikidata.org/entity/Q99957351> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q99957351 description "clinical trial" @default.
- Q99957351 description "ensayo clínico" @default.
- Q99957351 description "ensayu clínicu" @default.
- Q99957351 description "klinisch onderzoek" @default.
- Q99957351 description "клінічне випробування" @default.
- Q99957351 description "临床试验" @default.
- Q99957351 name "A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy" @default.
- Q99957351 name "A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy" @default.
- Q99957351 type Item @default.
- Q99957351 label "A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy" @default.
- Q99957351 label "A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy" @default.
- Q99957351 prefLabel "A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy" @default.
- Q99957351 prefLabel "A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy" @default.
- Q99957351 P1132 Q99957351-D79FAB9B-4948-4B0F-B537-AFE705EE8B19 @default.
- Q99957351 P1476 Q99957351-E96D8B3E-7A48-4D08-B80B-279216A042F7 @default.
- Q99957351 P2899 Q99957351-72A8A434-B252-4D35-BEEE-DEC9CAB75C6E @default.
- Q99957351 P3098 Q99957351-A3F7017D-AD7B-4615-9FD6-B159FB4869A6 @default.
- Q99957351 P31 Q99957351-455C0B9A-423E-4260-984E-1E0E509A30CB @default.
- Q99957351 P580 Q99957351-C24DC9BC-88CB-4FDE-A12B-1BA1851C084B @default.
- Q99957351 P582 Q99957351-EA0E1A64-ED7B-4251-A8A1-48386E73A363 @default.
- Q99957351 P6099 Q99957351-C853084A-C530-4CF0-875E-4310EDA50D6C @default.
- Q99957351 P8005 Q99957351-F0D185ED-3D83-4EE2-BEAA-F5E51DA1CCF4 @default.
- Q99957351 P8363 Q99957351-17951BDD-7FBA-4DA3-A481-D6152875F5CD @default.
- Q99957351 P859 Q99957351-B57B04CF-4B83-4193-B01C-561A76DE161B @default.
- Q99957351 P921 Q99957351-81739DC0-771E-43FB-8998-EE33A64B63F1 @default.
- Q99957351 P1132 "+410" @default.
- Q99957351 P1476 "A Multicenter Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label LNP023 in Patients With Primary IgA Nephropathy Who Have Completed Study CLNP023X2203 or CLNP023A2301" @default.
- Q99957351 P2899 "+18" @default.
- Q99957351 P3098 "NCT04557462" @default.
- Q99957351 P31 Q30612 @default.
- Q99957351 P580 "2021-02-17T00:00:00Z" @default.
- Q99957351 P582 "2028-05-26T00:00:00Z" @default.
- Q99957351 P6099 Q42824827 @default.
- Q99957351 P8005 Q76649614 @default.
- Q99957351 P8363 Q78089383 @default.
- Q99957351 P859 Q507154 @default.
- Q99957351 P921 Q605006 @default.